A small but mighty microbe that can safely extract the rare earth and other critical elements for building everything from ...

A Texas A&M scientist is using gene editing and other bioengineering to attack mosquito-borne diseases such as malaria, ...

The market outlook from the perspective of many biotech CEOs is grim. When the investment environment stabilized following ...

A new report from Pitchbook suggests we’re in for a period of more sustainable investing, with VC firms continuing to create ...

The lawsuit settlement happened over two years ago, and the Arkansas Pharmacists Association plans to use some money to help ...

The latest addition to The Woodlands’ life sciences core is open for business, and it could attract more businesses to the ...

TeamSense ranked all 50 states and the District of Columbia by their level of search interest in manufacturing topics.

Merck has held talks to buy Swiss biotech MoonLake Immunotherapeutics for more than $3 billion, the Financial Times reported ...

Wrapping up Q1 earnings, we look at the numbers and key takeaways for the branded pharmaceuticals stocks, including Pfizer ...

What Happened? Shares of biotech company Regeneron (NASDAQ:REGN) fell 19% in the afternoon session after the company ...

A US-based biotech company has successfully sequenced the genetic codes of preserved plants, some of which date back more ...

A lawsuit filed by a national pharmacy chain and its subsidiaries in the Little Rock federal court on Thursday seeks to ...